Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Direct vs Ultrasound Guided PECS Block for Postmastectomy Pain
NCT05825430Completed
- Sponsor
- Al-Azhar University
- Start
- Apr 2023
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of bupivacaine hydrochloride 0.75% injection in Post-mastectomy pain syndrome (PMPS) (3 arms), sponsored by Al-Azhar University. Primary endpoint: Total morphine consumption. Started Apr 2023; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
Post-mastectomy pain syndrome (PMPS)
Beyond the preview
Go deeper on NCT05825430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05825430.